BCC Research
View Existing Reports | Report Subscriptions | Upcoming Reports | Press Room
 

Pharmaceuticals

The U.S. Market For Prescription Ophthalmic Drugs  

Report Code: PHM031A, Published: August 2003

 

Click here for an updated version:  PHM031C

 
 

REPORT HIGHLIGHTS

  • The 2002 U.S. market for prescription ophthalmic drugs was $2.8 billion, and, rising at an average annual growth rate (AAGR) of 8.6%, will reach $4.5 billion in 2007.
  • Glaucoma treatments accounted for $1.4 billion in 2002 and will grow at an AAGR of 8.2% to more than $2 billion in 2007.
  • Products within the ocular infection and ocular allergy treatment segments follow in market presence, with $500 million and $397.1 million, respectively.
  • Ocular allergy treatment will lead growth with an AAGR of 10% through the period, reaching nearly $640 million

Report Code: PHM031A, Published: August 2003, Analyst: Melissa Elder

 
 

   Bookmark and Share


   

 Visit the Table of Contents  to purchase the report or to  download the introduction  chapter for free.



All transactions on our web site are conducted on a Secure SSL Server.
Copyright 2010 © All rights reserved.   About Us | Contact Us | Careers | Privacy Policy  |  Site Map |  XML Map